One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is applying ...

Discover why Editas Medicine (EDIT) targets high LDL cholesterol with in-the-body gene editing. Click here to read my most ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in.

If you have been staring at CRISPR Therapeutics stock lately, wondering whether it is time to buy, hold, or rethink your position, you are far from alone. Over the past week, the stock has surged 16.1 ...